VYNE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology.
CEODavid Domzalski
CEODavid Domzalski
Employees13
Employees13
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2011
Founded2011
Employees13
Employees13
VYNE Key Statistics
Market cap12.63M
Market cap12.63M
Price-Earnings ratio-0.48
Price-Earnings ratio-0.48
Dividend yield—
Dividend yield—
Average volume669.51K
Average volume669.51K
High today$0.3845
High today$0.3845
Low today$0.3597
Low today$0.3597
Open price$0.3792
Open price$0.3792
Volume393.04K
Volume393.04K
52 Week high$4.30
52 Week high$4.30
52 Week low$0.2805
52 Week low$0.2805
Stock Snapshot
With a market cap of 12.63M, VYNE Therapeutics(VYNE) trades at $0.37. The stock has a price-to-earnings ratio of -0.48.
As of 2025-12-04, VYNE Therapeutics(VYNE) stock has fluctuated between $0.36 and $0.38. The current price stands at $0.37, placing the stock +2.8% above today's low and -3.9% off the high.
VYNE Therapeutics(VYNE) shares are trading with a volume of 393.04K, against a daily average of 669.51K.
During the past year, VYNE Therapeutics(VYNE) stock moved between $0.28 at its lowest and $4.30 at its peak.
During the past year, VYNE Therapeutics(VYNE) stock moved between $0.28 at its lowest and $4.30 at its peak.
People also own
Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.